Overview
- Regional prosecutors in Bashkortostan, Dagestan, Tatarstan, the Kirov, Nizhny Novgorod, Omsk, Ryazan, Saratov and Ulyanovsk regions, and St. Petersburg were instructed to conduct oversight checks.
- The inspections will evaluate how regional authorities and medical institutions provide essential medicines to patients with kidney disease.
- An interagency analysis involving the Health Ministry, the Industry and Trade Ministry, and Roszdravnadzor is examining national production volumes and the circulation of relevant drugs.
- Bashkortostan’s Health Ministry denied supply disruptions and reported increased deliveries since September for drugs including epoetin alfa, paricalcitol, sevelamer, ferric carboxymaltose and etelcalcetide.
- The Prosecutor General’s Office pledged exhaustive measures for any violations and said results of the oversight actions remain under its control with findings not yet published.